Alimentary Pharmacology & Therapeutics, 0269-2813


  1. 2020
  2. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., van der Woude, C. J., Dijkstra, G., van der Meulen-de Jong, A. E., Lowenberg, M., ... Pierik, M. J. (2020). Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment. Alimentary Pharmacology & Therapeutics, 52(1).
  3. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., Sleutjes, J. A. M., de Vries, A. C., Bodelier, A. G. L., Dijkstra, G., ... Pierik, M. J. (2020). Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry. Alimentary Pharmacology & Therapeutics, 51(9), 880-888.
  4. 2019
  5. Dutch Autoimmune Hepatitis Study G, van den Brand, F. F., van der Veen, K. S., Lissenberg-Witte, B., de Boer, Y. S., van Hoek, B., ... Bouma, G. (2019). Adverse events related to low dose corticosteroids in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics.
  6. 2018
  7. Støy, S., Patel, V. C., Sturgeon, J. P., Manakkat Vijay, G. K., Lisman, T., Bernal, W., & Shawcross, D. L. (2018). Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion. Alimentary Pharmacology & Therapeutics, 47(10), 1375-1386.
  8. 2017
  9. van Tilborg, M., Lieveld, F. I., Smolders, E. J., van Erpecum, K. J., de Kanter, C. T. M. M., Maan, R., ... HepNed Study Grp (2017). Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals. Alimentary Pharmacology & Therapeutics, 46(9), 864-872.
  10. de Vries, F. E. E., Reeskamp, L. F., van Ruler, O., van Arum, I., Kuin, W., Dijksta, G., ... Serlie, M. J. (2017). Systematic review: pharmacotherapy for high-output enterostomies or enteral fistulas. Alimentary Pharmacology & Therapeutics, 46(3), 266-273.
  11. 2016
  12. Baranska, A., Mujagic, Z., Smolinska, A., Dallinga, J. W., Jonkers, D. M. A. E., Tigchelaar, E. F., ... van Schooten, F. J. (2016). Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach. Alimentary Pharmacology & Therapeutics, 44(1), 45-56.
  13. 2015
  14. 2013
  15. 2012
  16. Szajewska, H., Chmielewska, A., Pieścik-Lech, M., Ivarsson, A., Kolacek, S., Koletzko, S., ... PREVENTCD Study Group (2012). Systematic review: early infant feeding and the prevention of coeliac disease. Alimentary Pharmacology & Therapeutics, 36(7), 607-18.
  17. 2011
  18. Baven-Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., ... T. Brouwer, J. (2011). Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes: authors' reply. Alimentary Pharmacology & Therapeutics, 34(6), 684-685.
  19. Baven-Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., ... T. Brouwer, J. (2011). The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Alimentary Pharmacology & Therapeutics, 34(3), 335-343.
  20. 2010
  21. Van Geenen, E. J. M., De Boer, N. K. H., Stassen, P., Linskens, R. K., Bruno, M. J., Mulder, C. J. J., ... Van Bodegraven, A. A. (2010). Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon. Alimentary Pharmacology & Therapeutics, 31(12), 1322-1329.
  22. 2009
  23. Van Marrewijk, C. J., Van Oijen, M. G. H., Paloheimo, L. I., Fransen, G. A. J., Mujakovic, S., Muris, J. W. M., ... Jansen, J. B. M. J. (2009). Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Alimentary Pharmacology & Therapeutics, 30(1), 82-89.
  24. 2007
  25. 2006
  26. 2005
  27. 2004
Previous 1 2 Next

ID: 1266470